TrialClinical trialPHN-02612026-03-12 19:00 CT
A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems
Source · ClinicalTrials.gov: survodutide
TLDR
A ClinicalTrials.gov listing marks a study of BI 456906 in adults with and without kidney problems as completed. The study compared blood exposure across four kidney-function groups; the excerpt provides no results.
01—Key points
- 01BI 456906 is being developed to treat obesity and liver problems, according to the listing.
- 02The study included groups with normal kidney function and mild, moderate, or severe kidney problems.
- 03Researchers collected blood samples and monitored participants’ health and unwanted effects over about two months.
Why it matters Editorial
The study addresses whether kidney problems influence blood exposure to BI 456906, which the listing notes is relevant to people with obesity and liver problems.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.